149 material Form 8-K filings that 134 companies we cover made with the SEC in February 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
MYR Group reported fourth-quarter and full-year 2023 results on February 28, 2024, with full-year contract revenues of $3.64 billion, up 21.1 percent, and full-year net income of $91.0 million, or $5.40 per diluted share, up from $4.91 a year earlier. Fourth-quarter net income was $24.0 million, or $1.43 per diluted share, down from $1.46 in the same quarter of 2022, while fourth-quarter revenue rose 16.2 percent. The company's backlog was $2.51 billion at December 31, 2023.
Q4 2023 revenue was $1.00 billion, up $140.2 million or 16.2 percent from Q4 2022
Full-year 2023 net income was $91.0 million, or $5.40 per diluted share, versus $83.4 million, or $4.91 per diluted share, in 2022
Full-year gross margin fell to 10.0 percent from 11.4 percent, while Q4 net income declined 2.2 percent
Backlog was $2.51 billion at December 31, 2023, compared with $2.62 billion at September 30, 2023
Pure Storage reported fiscal fourth-quarter 2024 revenue of $789.8 million, down 3% from a year earlier, while full-year revenue rose 3% to $2.8 billion. Fourth-quarter GAAP operating income fell to $57.4 million from $64.6 million, and diluted EPS was $0.20 versus $0.22. The company guided fiscal 2025 revenue to $3.1 billion and authorized up to an additional $250 million in share repurchases.
Q4 revenue $789.8 million, down 3% year-over-year; subscription services revenue $328.9 million, up 24%
Full-year fiscal 2024 GAAP net income $61.3 million, versus $73.1 million in fiscal 2023
EMCOR reported record fourth-quarter and full-year 2023 revenue and diluted earnings per share, and its board approved a quarterly dividend increase to $0.25 per share from $0.18. The company also guided 2024 revenue to $13.5 billion-$14.0 billion and diluted EPS to $14.00-$15.00, above 2023 levels.
Q4 2023 revenue $3.44 billion, up 16.6%; Q4 diluted EPS $4.47 versus $2.63 a year earlier
Full-year 2023 revenue $12.58 billion, up 13.6%; diluted EPS $13.31 versus $8.10 in 2022
Equity LifeStyle Properties entered into equity distribution agreements with nine sales agents that allow it to sell up to $500 million of common stock from time to time. The company says proceeds may be used for general corporate purposes, including debt repayment, property acquisitions, and development. Shareholders may face dilution if the shares are sold, though the filing does not state any planned sale amount or timing.
Aggregate offering price of up to $500 million of common stock through nine sales agents
Agreements dated February 28, 2024, under a shelf registration filed the same day
Sales agents may receive commissions of up to 2.0% of gross sales price
Proceeds intended for general corporate purposes, including debt repayment and acquisitions
TG Therapeutics reported fourth quarter and full year 2023 results, furnished as Exhibit 99.1 to a Form 8-K. Full-year total revenue was $233.7 million, including a $140.0 million one-time payment from Neuraxpharm, and the company swung to net income of $12.7 million from a $198.3 million net loss in 2022. The company also set a 2024 BRIUMVI U.S. net product revenue target of $220 million to $260 million, giving shareholders a benchmark for future results.
Q4 2023 total revenue was $44.0 million versus $80 thousand in Q4 2022; Q4 net loss narrowed to $14.4 million from $53.0 million.
Full-year 2023 BRIUMVI U.S. net product revenue was $88.8 million; license, milestone and other revenue was $141.7 million, mainly from the $140.0 million Neuraxpharm payment received in July 2023.
2024 targets: BRIUMVI U.S. net product revenue of approximately $220 million to $260 million and total operating expense of approximately $250 million.
Year-end 2023 cash, cash equivalents and investment securities were $217.5 million.
OneSpaWorld reported fourth quarter 2023 revenue up 15% to $194.8 million and full-year revenue up 45% to $794.0 million, with Adjusted EBITDA up 13% in the quarter and 77% for the year. GAAP results were weaker: the company posted a fourth-quarter net loss of $7.3 million and a full-year net loss of $3.0 million, compared with a full-year net income of $53.2 million in 2022, largely due to changes in the fair value of warrant liabilities and a $5.4 million deleveraging fee. The company reaffirmed its fiscal 2024 guidance and gave first-quarter 2024 guidance.
Q4 2023 revenue $194.8 million, up 15% from $168.9 million; net loss $7.3 million, or $0.07 per diluted share, versus a $2.3 million net loss in Q4 2022
Full-year 2023 revenue $794.0 million, up 45%; net loss $3.0 million, or $0.03 per diluted share, versus net income of $53.2 million in 2022
Warrant liability fair value change was a $10.8 million loss in Q4 2023 and a $37.6 million loss for the year; a $5.4 million deleveraging fee was also recorded
Guidance: Q1 2024 revenue $204-209 million and Adjusted EBITDA $21.5-23.5 million; fiscal 2024 revenue $850-870 million and Adjusted EBITDA $90-100 million, reaffirmed
Warby Parker reported fourth quarter and full year 2023 results on February 28, 2024. Full year net revenue rose 12.0% to $669.8 million, and the GAAP net loss narrowed to $63.2 million from $110.4 million in 2022. The company also guided to 2024 net revenue of $748 million to $758 million, about 12% to 13% growth, and adjusted EBITDA of about $67 million at the revenue midpoint.
Full year 2023 net revenue increased 12.0% to $669.8 million; fourth quarter net revenue rose 10.5% to $161.9 million.
Full year GAAP net loss was $63.2 million, versus $110.4 million in 2022; fourth quarter GAAP net loss was $19.0 million.
2024 outlook: net revenue of $748 million to $758 million and adjusted EBITDA of $67 million at the revenue midpoint, with 40 new store openings planned.
Gross margin fell to 54.5% from 57.0% in 2022, which the company attributed mainly to growth in lower-margin contact lenses.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.